KORU Medical Systems (KRMD) Competitors

$4.16 +0.16 (+3.98%)

As of 02:49 PM Eastern

KRMD vs. BWAY, AVR, TCMD, NPCE, and MDXG

Should you buy KORU Medical Systems stock or one of its competitors? MarketBeat compares KORU Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with KORU Medical Systems include Brainsway (BWAY), Anteris Technologies Global (AVR), Tactile Systems Technology (TCMD), NeuroPace (NPCE), and MiMedx Group (MDXG). These companies are all part of the "medical equipment" industry.

How does KORU Medical Systems compare to Brainsway?

Brainsway (NASDAQ:BWAY) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

Brainsway presently has a consensus price target of $15.00, indicating a potential downside of 0.30%. KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 74.32%. Given KORU Medical Systems' higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Brainsway	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Brainsway has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Brainsway	$52.22M	11.54	$7.57M	$0.35	42.99
KORU Medical Systems	$41.13M	4.64	-$2.64M	-$0.05	N/A

Brainsway has a net margin of 15.68% compared to KORU Medical Systems' net margin of -5.27%. Brainsway's return on equity of 12.28% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Brainsway	15.68%	12.28%	7.75%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

Brainsway has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market.

30.1% of Brainsway shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, KORU Medical Systems had 5 more articles in the media than Brainsway. MarketBeat recorded 7 mentions for KORU Medical Systems and 2 mentions for Brainsway. KORU Medical Systems' average media sentiment score of 0.97 beat Brainsway's score of 0.24 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Brainsway	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
KORU Medical Systems	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Brainsway beats KORU Medical Systems on 11 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

58.6% of KORU Medical Systems shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

KORU Medical Systems has a net margin of -5.27% compared to Anteris Technologies Global's net margin of -5,148.78%. KORU Medical Systems' return on equity of -13.61% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

In the previous week, KORU Medical Systems had 5 more articles in the media than Anteris Technologies Global. MarketBeat recorded 7 mentions for KORU Medical Systems and 2 mentions for Anteris Technologies Global. KORU Medical Systems' average media sentiment score of 0.97 beat Anteris Technologies Global's score of -0.08 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
KORU Medical Systems	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Anteris Technologies Global has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than Anteris Technologies Global. KORU Medical Systems is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	465.19	-$94.14M	-$2.23	N/A
KORU Medical Systems	$41.13M	4.64	-$2.64M	-$0.05	N/A

Anteris Technologies Global currently has a consensus price target of $16.00, indicating a potential upside of 75.28%. KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 74.32%. Given Anteris Technologies Global's higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

KORU Medical Systems beats Anteris Technologies Global on 10 of the 14 factors compared between the two stocks.

How does KORU Medical Systems compare to Tactile Systems Technology?

KORU Medical Systems (NASDAQ:KRMD) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

KORU Medical Systems has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Tactile Systems Technology has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.64	-$2.64M	-$0.05	N/A
Tactile Systems Technology	$329.52M	1.74	$19.09M	$0.88	28.94

KORU Medical Systems currently has a consensus price target of $7.25, suggesting a potential upside of 74.32%. Tactile Systems Technology has a consensus price target of $38.60, suggesting a potential upside of 51.58%. Given KORU Medical Systems' higher possible upside, equities analysts clearly believe KORU Medical Systems is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

Tactile Systems Technology has a net margin of 5.91% compared to KORU Medical Systems' net margin of -5.27%. Tactile Systems Technology's return on equity of 9.70% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Tactile Systems Technology	5.91%	9.70%	7.53%

In the previous week, KORU Medical Systems had 2 more articles in the media than Tactile Systems Technology. MarketBeat recorded 7 mentions for KORU Medical Systems and 5 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 1.00 beat KORU Medical Systems' score of 0.97 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Tactile Systems Technology beats KORU Medical Systems on 12 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

KORU Medical Systems has lower revenue, but higher earnings than NeuroPace. KORU Medical Systems is trading at a lower price-to-earnings ratio than NeuroPace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.53M	5.57	-$21.47M	-$0.65	N/A
KORU Medical Systems	$41.13M	4.64	-$2.64M	-$0.05	N/A

KORU Medical Systems has a net margin of -5.27% compared to NeuroPace's net margin of -21.67%. KORU Medical Systems' return on equity of -13.61% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-21.67%	-108.20%	-18.50%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

In the previous week, NeuroPace had 6 more articles in the media than KORU Medical Systems. MarketBeat recorded 13 mentions for NeuroPace and 7 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.97 beat NeuroPace's score of 0.67 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroPace	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KORU Medical Systems	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeuroPace has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market.

NeuroPace currently has a consensus target price of $18.83, suggesting a potential upside of 15.75%. KORU Medical Systems has a consensus target price of $7.25, suggesting a potential upside of 74.32%. Given KORU Medical Systems' higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 20.5% of NeuroPace shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

NeuroPace beats KORU Medical Systems on 9 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 2.5% of MiMedx Group shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

MiMedx Group currently has a consensus target price of $8.50, indicating a potential upside of 132.88%. KORU Medical Systems has a consensus target price of $7.25, indicating a potential upside of 74.32%. Given MiMedx Group's stronger consensus rating and higher probable upside, analysts clearly believe MiMedx Group is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, KORU Medical Systems had 3 more articles in the media than MiMedx Group. MarketBeat recorded 7 mentions for KORU Medical Systems and 4 mentions for MiMedx Group. KORU Medical Systems' average media sentiment score of 0.97 beat MiMedx Group's score of 0.15 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiMedx Group	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
KORU Medical Systems	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiMedx Group has a net margin of 7.88% compared to KORU Medical Systems' net margin of -5.27%. MiMedx Group's return on equity of 21.03% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

MiMedx Group has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$389.42M	1.40	$48.58M	$0.20	18.25
KORU Medical Systems	$41.13M	4.64	-$2.64M	-$0.05	N/A

MiMedx Group has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

Summary

MiMedx Group beats KORU Medical Systems on 12 of the 16 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KRMD vs. The Competition

Export

Metric	KORU Medical Systems	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$191.53M	$1.45B	$6.33B	$12.33B
Dividend Yield	N/A	N/A	2.80%	5.36%
P/E Ratio	-83.40	64.21	20.88	25.51
Price / Sales	4.64	6.29	520.50	73.06
Price / Cash	N/A	22.71	43.18	55.00
Price / Book	11.24	6.05	10.01	7.03
Net Income	-$2.64M	-$54.76M	$3.54B	$334.92M
7 Day Performance	4.50%	6.36%	0.38%	-0.40%
1 Month Performance	3.46%	9.87%	-0.02%	1.07%
1 Year Performance	48.54%	0.63%	35.07%	34.65%

KORU Medical Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KRMD KORU Medical Systems	4.3909 of 5 stars	$4.16 +4.0%	$7.25 +74.3%	+35.6%	$191.53M	$41.13M	N/A	80	News Coverage
BWAY Brainsway	2.4631 of 5 stars	$16.74 +0.1%	$15.00 -10.4%	+185.9%	$669.83M	$52.22M	66.96	120	High Trading Volume
AVR Anteris Technologies Global	2.8779 of 5 stars	$6.70 +2.9%	$15.33 +128.9%	+125.7%	$632.98M	$1.91M	N/A	138
TCMD Tactile Systems Technology	4.2 of 5 stars	$23.53 -1.5%	$38.60 +64.0%	+138.8%	$539.09M	$329.52M	26.74	1,086	Positive News Analyst Forecast
NPCE NeuroPace	3.4014 of 5 stars	$15.80 +0.8%	$18.67 +18.1%	-9.6%	$532M	$99.99M	N/A	170	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KRMD) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KORU Medical Systems (KRMD) Competitors

KRMD vs. BWAY, AVR, TCMD, NPCE, and MDXG

How does KORU Medical Systems compare to Brainsway?

Summary

How does KORU Medical Systems compare to Anteris Technologies Global?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Summary

How does KORU Medical Systems compare to NeuroPace?

Summary

How does KORU Medical Systems compare to MiMedx Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KORU Medical Systems (KRMD) Competitors

KRMD vs. BWAY, AVR, TCMD, NPCE, and MDXG

How does KORU Medical Systems compare to Brainsway?

Do analysts rate BWAY or KRMD?

Which has preferable valuation and earnings, BWAY or KRMD?

Is BWAY or KRMD more profitable?

Which has more volatility & risk, BWAY or KRMD?

Do institutionals and insiders believe in BWAY or KRMD?

Does the media refer more to BWAY or KRMD?

Summary

How does KORU Medical Systems compare to Anteris Technologies Global?

Do insiders and institutionals have more ownership in AVR or KRMD?

Is AVR or KRMD more profitable?

Does the media refer more to AVR or KRMD?

Which has more risk & volatility, AVR or KRMD?

Which has preferable valuation and earnings, AVR or KRMD?

Do analysts recommend AVR or KRMD?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Which has more volatility & risk, KRMD or TCMD?

Do insiders & institutionals hold more shares of KRMD or TCMD?

Which has better valuation & earnings, KRMD or TCMD?

Do analysts prefer KRMD or TCMD?

Is KRMD or TCMD more profitable?

Does the media favor KRMD or TCMD?

Summary

How does KORU Medical Systems compare to NeuroPace?

Which has preferable valuation and earnings, NPCE or KRMD?

Is NPCE or KRMD more profitable?

Does the media refer more to NPCE or KRMD?

Which has more risk & volatility, NPCE or KRMD?

Do analysts prefer NPCE or KRMD?

Do institutionals & insiders hold more shares of NPCE or KRMD?

Summary

How does KORU Medical Systems compare to MiMedx Group?

Do insiders & institutionals have more ownership in MDXG or KRMD?

Do analysts recommend MDXG or KRMD?

Does the media refer more to MDXG or KRMD?

Is MDXG or KRMD more profitable?

Which has better earnings & valuation, MDXG or KRMD?

Which has more risk and volatility, MDXG or KRMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools